Barts Charity

Barts Charity, one of the UK’s oldest medical charities with roots tracing back centuries, supports St Bartholomew’s Hospital and Barts Health NHS Trust, including The Royal London, Whipps Cross, Newham, and Mile End Hospitals, alongside Queen Mary University of London’s Faculty of Medicine and Dentistry. Its mission is to advance health in East London’s diverse communities by funding transformative research and healthcare innovation that tackles entrenched inequalities, guided by values of inclusivity, equity, collaboration, compassion, and measurable impact. Distinctively, it acts as a strategic catalyst for bold, unfunded ideas, committing over £150 million in its 2022-27 plan to pioneer systemic improvements through partnerships between clinicians, academics, and communities.

It prioritizes pioneering research in cancer, cardiovascular disease, mental health, health data science, and staff wellbeing, funding projects like a £16.6m Breast Cancer Centre, £14m Clinical Research Facility, and £5.8m Data Platform. Supported activities span translational studies, clinical pilots, infrastructure, equipment, seed funding, and capacity-building for patient care enhancements benefiting Barts Health patients, NHS staff, and local residents facing chronic challenges.

Eligibility is restricted to staff or affiliates of Barts Health NHS Trust, Queen Mary University of London, and select East London partners delivering benefits in Barking and Dagenham, City of London, Hackney, Newham, Redbridge, Tower Hamlets, or Waltham Forest; UK-registered charities and academic institutions must have strong local ties and research capacity, favoring large entities over small grassroots groups. Grants range from £5,000–£75,000 (small, up to 18 months) to £75,000–£600,000 (large/project, up to 36 months), via scheme-specific online forms with two-stage processes for bigger awards, internal approvals, and deadlines like 19 March 2026 for small grants or 28 May 2026 for projects.

Barts Charity rejects unsolicited applications from non-partners, core costs (unless scheme-allowed), and projects outside its geography or priorities, standing out for its hyper-local focus on East London’s multicultural health disparities, entrepreneurial backing of high-risk innovations, and NHS-academic collaborations driving precision medicine and equity.